2Morrow Offers SmartQuit® Program in Spanish to Help More Smokers Quit
Kirkland, WASHINGTON -- June 21, 2016 -- 2Morrow, Inc. announced their clinically tested smoking cessation app, SmartQuit®, now supports Spanish-language smokers who want to quit. The program uses a unique acceptance and commitment therapy (ACT) approach to help smokers learn new ways to deal with their cravings.
Over 39 million people speak Spanish at home in the United States making Spanish the second most commonly spoken language in the United States.[i] According to the Centers for Disease Control, the leading causes of death among Hispanics/Latinos include: cancer, heart disease, diabetes and stroke - all of which can be caused by cigarette smoking. In addition, Spanish-speaking Americans often have less access to healthcare than the general population resulting in less access to cessation treatments.[ii]
“By offering SmartQuit in Spanish, 2Morrow hopes to make clinically tested smoking cessation techniques more accessible to underserved communities in the United States,” says Brandon Masterson, CEO of 2Morrow. “Spanish language support is an important step in reaching more smokers.”
The Spanish translation of SmartQuit was partially funded by the Washington State Department of Health and the CDC Prevention and Public Health Fund. So far, “Almost 1000 residents of Washington State have used SmartQuit to help them quit,” reports Joella Pyatt, Cessation Services Consultant at the Washington State Department of Health. With over 550,000 people living in Washington State that speak Spanish at home, the new version will help reach a different group of smokers.
In a recent clinical trial by researchers at Fred Hutchinson Cancer Research Center and funded by a Life Sciences Discovery Fund grant, SmartQuit participants were about twice as likely to quit smoking as those who try to quit on their own. And, people who completed the core program saw quit rates of about 28% - which is significantly higher than the 4-5% of smokers who successfully quit on their own.[iii] This data supports findings from a previous randomized control trial of the SmartQuit app.[iv] A larger, longer study funded by the NIH and conducted by the Fred Hutchinson Cancer Research Center will be launched later this year.
A lite version of the SmartQuit program is available in the iTunes or Google Play app stores. The full version is available via in-app upgrade or though some employers, health plans, groups or state programs. After downloading the app, SmartQuit participants that have their smartphone default language set to Spanish will automatically see the Spanish-language version.
About 2Morrow, Inc.
2Morrow® is a digital health company dedicated to improving millions of lives with the use of evidence-based, behavior change programs delivered using mobile technology (mhealth). We distribute our programs mostly through employers, states, wellness programs and health plans. SmartQuit® is the first clinically tested smoking cessation program shown to help smokers quit. It is powered by 2Morrow’s behavior change engine and delivered via a mobile app.
- About 2Morrow, Inc. http://www.2morrowinc.com/about-us/
- SmartQuit webpage: http://www.2morrowinc.com/smartquit/
- SmartQuit for WA State residents http://www.doh.wa.gov/YouandYourFamily/Tobacco/SmartQuit
- SmartQuit for LA State residents: https://smartquit.net/wellahead
- 2Morrow, Inc.
- Jo Masterson, COO at 2Morrow, Inc.
- jmasterson @ 2morrowinc.com
[iii] Bricker, J., Copeland, W., & Heffner, J., (2016). Trial of an acceptance & commitment therapy smartphone application for smoking cessation among primarily low SES female smokers. (SYM19B), 26. Abstract retrieved from Society for Research on Nicotine & Tobacco 2016 Annual Meeting Abstracts, Chicago, IL.
[iv] Jonathan B. Bricker, Kristin E. Mull, Julie A. Kientz, Roger Vilardaga, Laina D. Mercer, Katrina J. Akioka, Jaimee L. Heffner (October, 2014). Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug and Alcohol Dependence, Volume 143, Pages 87–94.